Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Bioscience Reports|November 22, 2015
Nucleotide-binding mechanisms in pseudokinasesHenrik M Hammarén, Anniina T Virtanen, Olli SilvennoinenBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 2019
Selective JAKinibs: Prospects in Inflammatory and Autoimmune DiseasesAnniina T Virtanen, Teemu Haikarainen, Juuli Raivola, et al.Nature Reviews. Drug Discovery|January 4, 2026
Pharmacological targeting of the JAK-STAT pathway: new concepts and emerging indicationsTeemu Haikarainen, Anniina T Virtanen, Benjamin F Cravatt, et al.Cytokine|April 25, 2018
The regulation of JAKs in cytokine signaling and its breakdown in diseaseHenrik M Hammarén, Anniina T Virtanen, Juuli Raivola, et al.Frontiers in Oncology|December 19, 2018
Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase DomainJuuli Raivola, Henrik M Hammarén, Anniina T Virtanen, et al.The Journal of Allergy and Clinical Immunology|August 10, 2018
Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutationsHenrik M Hammarén, Anniina T Virtanen, Bobin George Abraham, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase DomainAnniina T Virtanen, Teemu Haikarainen, Parthasarathy Sampathkumar, et al.Science Advances|March 8, 2024
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signalingBobin George Abraham, Teemu Haikarainen, Joni Vuorio, et al.Cell Chemical Biology|June 8, 2023
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutationMatthew L Arwood, Yao Liu, Shannon K Harkins, et al.Science Advances|April 30, 2025
Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypesEmil Hiitola, Juuso Korhonen, Heidi Kokkonen, et al.Pageof 1